Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;16(3):3-6.
doi: 10.3747/co.v16i3.447.

Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?

A Hauschild  1
Affiliations

Adjuvant interferon alfa for melanoma: new evidence-based treatment recommendations?

A Hauschild. Curr Oncol. 2009 May.
No abstract available

Keywords: Melanoma; adjuvant therapy; interferon alfa.

PubMed Disclaimer

References

    1. Schuchter LM. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose? J Clin Oncol. 2004;22:7–10. - PubMed
    1. Hauschild A, Schadendorf D, Garbe C, Ugurel S, Kähler KC. New promises in the adjuvant, and palliative treatment of melanoma. Cancer Treat Res. 2007;135:277–92. - PubMed
    1. Wheatley K, Ives N, Eggermont A, et al. on behalf of the International Malignant Melanoma Collaborative Group Interferon-α as adjuvant therapy for melanoma: an individual patient data meta-analysis of randomised trials [abstract 8526] Proc Am Soc Clin Oncol. 2007;25 [Available online at: www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_d...; cited March 30, 2009]
    1. Kirkwood JM, Manola J, Ibrahim J, Sondak V, Ernstoff MS. Rao U on behalf of the Eastern Cooperative Oncology Group. A pooled analysis of Eastern Cooperative Oncology Group and Intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res. 2004;10:1670–7. - PubMed
    1. Kilbridge KL, Cole BF, Kirkwood JM, et al. Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using Intergroup clinical trial data. J Clin Oncol. 2002;20:1311–18. - PubMed

LinkOut - more resources